Kusajili – Clinical trials directory

Result of your search per sponsor: Sanofi-Aventis Deutschland GmbH (Germany)

Woman and Man Max 99 years
Sanofi-Aventis Deutschland GmbH (Germany) Update Il y a 4 ans

Oxaliplatin/folinic acid/5-fluorouracil (24-hour) (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advanced pancreatic cancer Not provided at time of registration

Country None
organs None
Specialty None

Closed trial

More information